TRX-920

· TaiRx, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TRX-920, covering 2026-04-13 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: Study of TRX-920 for Patients With Advanced Solid Tumors [Phase 1]